Truncation of the neuritogenic peptide bP2(60-70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation

Journal of Neuroimmunology

Volumn 129, Issue 1-2, 2002, Pages 97-105

  Offenhäusser, Martin ^a   Herr, Alexandra S ^a   Hartkamp, Jörg ^b   Wauben, Marca ^c   Magnus, Tim ^a   Grauer, Oliver ^a   Seubert, Silvia ^a   Weishaupt, Andreas ^a   Toyka, Klaus V ^a   Gold, Ralf ^a   Troppmair, Jakob ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

APL; EAE, experimental autoimmune encephalomyelitis; EAN; Signaling; T cells

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN BASIC PROTEIN; PEPTIDE; PEPTIDE BP2[60-69]; PEPTIDE BP2[60-70]; PEPTIDE BP2[61-69]; PEPTIDE BP2[61-70]; PEPTIDE BP2[62-68]; PEPTIDE BP2[62-69]; PEPTIDE BP2[63-69]; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; FEMALE; IC 50; IMMUNE RESPONSE; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; NEURITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CELL DIVISION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; LIGANDS; MOLECULAR WEIGHT; MYELIN P2 PROTEIN; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, INBRED LEW; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0036346759     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00183-2     Document Type: Article

References (42)

1. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: Implications for TCR signaling
2. Antigen-specific immunomodulation via altered peptide ligands
3. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
4. Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1
5. P27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes
6. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles
7. Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands
8. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
9. T helper cell epitope of rabies virus nucleoprotein defined by tri- and tetrapeptides
10. Blocked Ras activation in anergic CD4+ T cells
11. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
12. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique
13. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule
14. Minimal peptide length requirements for CD4(+) T cell clones - Implications for molecular mimicry and T cell survival
15. GTPases in antigen receptor signalling
16. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules
17. Short peptide-based tolerogens without self-antigenic or pathogenic activity reverse autoimmune disease
18. Essential flexibility in the T-cell recognition of antigen
19. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment
20. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells
21. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo
22. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists
23. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists
24. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells
25. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
26. New minimum length requirement for a T cell epitope for experimental allergic neuritis
27. Mitogen-activated protein (map) kinase pathways: Regulation and physiological functions
28. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes
29. The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI
30. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology
31. Th2 cell clonal anergy as a consequence of partial activation
32. Partial T cell signaling: Altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy
33. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
34. Heterogeneity of T-cell receptor usage in experimental autoimmune neuritis in the Lewis rat
35. JNK is involved in signal integration during costimulation of T lymphocytes
36. Serial triggering of TCRs: A basis for the sensitivity and specificity of antigen recognition
37. T cell activation determined by T cell receptor number and tunable thresholds
38. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides
39. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals
40. Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule
41. Antigen therapy eliminates T cell inflammation by apoptosis: Effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2
42. T cell inactivation linked to Ras block